Defining Patient-Level Molecular Heterogeneity in Psoriasis Vulgaris Based on Single-Cell Transcriptomics
Yale Liu(Second Affiliated Hospital of Xi'an Jiaotong University), Raymond J. Cho(University of California, San Francisco), Jeffrey B. Cheng(Cleveland Clinic), Elizabeth Purdom(University of California, Berkeley), Ashley Hailer(University of California, San Francisco), Arsil Sadik(San Francisco VA Medical Center), Mark A. Taylor, Hao Wang(Stockholm University), Esther Kim(Icahn School of Medicine at Mount Sinai), Yanhong Shou(Second Affiliated Hospital of Zhejiang University), Christopher Cook(Imperial College London), Jeffrey P. North(University of California, San Francisco)
Cited by 19
Related Papers
Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase
|Proceedings of the National Academy of Sciences|2004|745
Subtype and pathway specific responses to anticancer compounds in breast cancer
|Proceedings of the National Academy of Sciences|2011|505
Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation
|Cell Death and Disease|2021|230